Fangrong Shen

1.2k total citations
45 papers, 783 citations indexed

About

Fangrong Shen is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Fangrong Shen has authored 45 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 17 papers in Cancer Research and 10 papers in Immunology. Recurrent topics in Fangrong Shen's work include MicroRNA in disease regulation (11 papers), Circular RNAs in diseases (11 papers) and Cancer-related molecular mechanisms research (10 papers). Fangrong Shen is often cited by papers focused on MicroRNA in disease regulation (11 papers), Circular RNAs in diseases (11 papers) and Cancer-related molecular mechanisms research (10 papers). Fangrong Shen collaborates with scholars based in China, United States and Italy. Fangrong Shen's co-authors include Feng Ma, Yi Yuan, Jinhua Zhou, Lanlan Feng, Youguo Chen, Youguo Chen, Juan Wang, Weiwen Yang, Yuejuan Xu and Yan Li and has published in prestigious journals such as Journal of Biological Chemistry, Frontiers in Immunology and Gene.

In The Last Decade

Fangrong Shen

44 papers receiving 773 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangrong Shen China 17 346 260 163 144 127 45 783
Yarong Song China 17 519 1.5× 343 1.3× 242 1.5× 269 1.9× 87 0.7× 42 1.1k
Kiyoko Umene Japan 18 397 1.1× 267 1.0× 109 0.7× 155 1.1× 75 0.6× 32 841
Shu Soeda Japan 14 144 0.4× 106 0.4× 205 1.3× 180 1.3× 126 1.0× 67 702
Chiao‐Yun Lin Taiwan 18 410 1.2× 146 0.6× 151 0.9× 106 0.7× 81 0.6× 71 822
Ruifang An China 15 175 0.5× 87 0.3× 198 1.2× 103 0.7× 99 0.8× 58 628
Won Duk Joo South Korea 16 264 0.8× 202 0.8× 150 0.9× 138 1.0× 46 0.4× 41 662
Tomohito Tanaka Japan 18 348 1.0× 208 0.8× 291 1.8× 333 2.3× 97 0.8× 81 1.0k
Huaijun Zhou China 14 291 0.8× 242 0.9× 88 0.5× 87 0.6× 62 0.5× 38 523
Rutie Yin China 16 296 0.9× 160 0.6× 319 2.0× 126 0.9× 84 0.7× 120 997
Qizhi He China 21 603 1.7× 244 0.9× 291 1.8× 330 2.3× 364 2.9× 62 1.3k

Countries citing papers authored by Fangrong Shen

Since Specialization
Citations

This map shows the geographic impact of Fangrong Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangrong Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangrong Shen more than expected).

Fields of papers citing papers by Fangrong Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangrong Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangrong Shen. The network helps show where Fangrong Shen may publish in the future.

Co-authorship network of co-authors of Fangrong Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Fangrong Shen. A scholar is included among the top collaborators of Fangrong Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangrong Shen. Fangrong Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Zhenyu, et al.. (2025). Detection of nontoxic BoNT/A levels in post-facial Botox injection breastmilk. PubMed. 4. 1480515–1480515. 1 indexed citations
2.
Shen, Fangrong, et al.. (2024). Exosomal miR-4516 derived from ovarian cancer stem cells enhanced cisplatin tolerance in ovarian cancer by inhibiting GAS7. Gene. 927. 148738–148738. 6 indexed citations
3.
Ding, Hongmei, Juan Wang, Xiaoyu Zhao, et al.. (2024). Combination of circulating tumor cells, lncRNAs and DNA methylation for the diagnosis of endometrial carcinoma. Oncology Letters. 28(5). 545–545. 2 indexed citations
4.
Shi, Yajun, Fangrong Shen, Xionghui Chen, Miao Sun, & Pengjie Zhang. (2024). Current understanding of circular RNAs in preeclampsia. Hypertension Research. 47(6). 1607–1619. 1 indexed citations
5.
Sha, Ying, et al.. (2024). A meta-analysis of efficacy on dexamethasone and clomiphene in the treatment of polycystic ovary syndrome patients. BMC Women s Health. 24(1). 298–298. 2 indexed citations
6.
Li, Yang, Wenwen Wang, Jingluan Tian, et al.. (2023). Clinical Significance of Soluble LAG-3 (sLAG-3) in Patients With Cervical Cancer Determined via Enzyme-Linked Immunosorbent Assay With Monoclonal Antibodies. Technology in Cancer Research & Treatment. 22. 2223944538–2223944538. 7 indexed citations
7.
Li, Shuping, et al.. (2023). A first-in-class POLRMT specific inhibitor IMT1 suppresses endometrial carcinoma cell growth. Cell Death and Disease. 14(2). 152–152. 16 indexed citations
8.
Li, Yang, et al.. (2023). Research Progress of Immuno-Inhibitory Receptors in Gynecological Cervical Cancer. Technology in Cancer Research & Treatment. 22. 2223950734–2223950734.
9.
Sha, Ying, et al.. (2023). Exploring the Diagnostic Potential of EPB41L3 Methylation in Cervical Cancer and Precancerous Lesions: A Systematic Review and Meta-Analysis. Gynecologic and Obstetric Investigation. 89(1). 1–10. 2 indexed citations
10.
Xu, Yuejuan, Chunjie Wang, Fangrong Shen, et al.. (2022). Lipid-Coated CaCO3 Nanoparticles as a Versatile pH-Responsive Drug Delivery Platform to Enable Combined Chemotherapy of Breast Cancer. ACS Applied Bio Materials. 5(3). 1194–1201. 28 indexed citations
11.
Shen, Fangrong, et al.. (2022). Identification of Candidate Gene Signatures and Regulatory Networks in Endometriosis and its Related Infertility by Integrated Analysis. Reproductive Sciences. 29(2). 411–426. 4 indexed citations
12.
Wang, Ping, Juan Wang, Jinhua Zhou, et al.. (2022). Hyperthermia enhances the efficacy of chemotherapeutic drugs in heat-sensitive cells through interfering with DNA damage repair. Annals of Translational Medicine. 10(8). 463–463. 7 indexed citations
13.
Wang, Juan, Yuhong Wu, Yan Li, et al.. (2021). Guanosine monophosphate synthase upregulation mediates cervical cancer progression by inhibiting the apoptosis of cervical cancer cells via the Stat3/P53 pathway. International Journal of Oncology. 58(4). 16 indexed citations
14.
Zhang, Yi, Fangrong Shen, Weiwen Yang, et al.. (2020). Effects of low‐molecular‐weight heparin and aspirin in recurrent pre‐eclampsia: A stratified cohort study. International Journal of Gynecology & Obstetrics. 154(2). 337–342. 5 indexed citations
15.
Feng, Lanlan, et al.. (2019). Expression of the lncRNA ZFAS1 in cervical cancer and its correlation with prognosis and chemosensitivity. Gene. 696. 105–112. 42 indexed citations
16.
Zhou, Jinhua, Yinghui Zhang, Li Wang, et al.. (2019). Aberrantly Expressed Timeless Regulates Cell Proliferation and Cisplatin Efficacy in Cervical Cancer. Human Gene Therapy. 31(5-6). 385–395. 21 indexed citations
17.
Shen, Fangrong, Lanlan Feng, Jinhua Zhou, et al.. (2019). Overexpression of CASC11 in ovarian squamous cell carcinoma mediates the development of cancer cell resistance to chemotherapy. Gene. 710. 363–366. 15 indexed citations
18.
Wang, Juan, Yamei Wang, Fangrong Shen, et al.. (2018). Maternal embryonic leucine zipper kinase: A novel biomarker and a potential therapeutic target of cervical cancer. Cancer Medicine. 7(11). 5665–5678. 21 indexed citations
19.
Huang, Yan, Lenard M. Lichtenberger, Morgan Taylor, et al.. (2016). Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian Cancer. Molecular Cancer Therapeutics. 15(12). 2894–2904. 42 indexed citations
20.
Shen, Fangrong, Lu Wang, Weiwen Yang, & Youguo Chen. (2015). From appearance to essence: 10 years review of atypical amniotic fluid embolism. Archives of Gynecology and Obstetrics. 293(2). 329–334. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yarong Song Breakdown of academic impact, for papers by Kiyoko Umene Breakdown of academic impact, for papers by Shu Soeda Breakdown of academic impact, for papers by Chiao‐Yun Lin Breakdown of academic impact, for papers by Ruifang An Breakdown of academic impact, for papers by Won Duk Joo Breakdown of academic impact, for papers by Tomohito Tanaka Breakdown of academic impact, for papers by Huaijun Zhou Breakdown of academic impact, for papers by Rutie Yin Breakdown of academic impact, for papers by Qizhi He
Rankless by CCL
2026